» Articles » PMID: 33624100

Utility of Risk Prediction Models to Detect Atrial Fibrillation in Screened Participants

Overview
Date 2021 Feb 24
PMID 33624100
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Atrial fibrillation (AF) is associated with higher risk of stroke. While the prevalence of AF is low in the general population, risk prediction models might identify individuals for selective screening of AF. We aimed to systematically identify and compare the utility of established models to predict prevalent AF.

Methods And Results: Systematic search of PubMed and EMBASE for risk prediction models for AF. We adapted established risk prediction models and assessed their predictive performance using data from 2.5M individuals who attended vascular screening clinics in the USA and the UK and in the subset of 1.2M individuals with CHA2DS2-VASc ≥2. We assessed discrimination using area under the receiver operating characteristic (AUROC) curves and agreement between observed and predicted cases using calibration plots. After screening 6959 studies, 14 risk prediction models were identified. In our cohort, 10 464 (0.41%) participants had AF. For discrimination, six prediction model had AUROC curves of 0.70 or above in all individuals and those with CHA2DS2-VASc ≥2. In these models, calibration plots showed very good concordance between predicted and observed risks of AF. The two models with the highest observed prevalence in the highest decile of predicted risk, CHARGE-AF and MHS, showed an observed prevalence of AF of 1.6% with a number needed to screen of 63. Selective screening of the 10% highest risk identified 39% of cases with AF.

Conclusion: Prediction models can reliably identify individuals at high risk of AF. The best performing models showed an almost fourfold higher prevalence of AF by selective screening of individuals in the highest decile of risk compared with systematic screening of all cases.

Registration: This systematic review was registered (PROSPERO CRD42019123847).

Citing Articles

Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.

Kostopoulos G, Effraimidis G Eur Thyroid J. 2024; 13(2).

PMID: 38377675 PMC: 11046323. DOI: 10.1530/ETJ-23-0254.


Analyses of m6A regulatory genes and subtype classification in atrial fibrillation.

Zhao Y, Che Y, Liu Q, Zhou S, Xiao Y Front Cell Neurosci. 2023; 17:1073538.

PMID: 37435047 PMC: 10330950. DOI: 10.3389/fncel.2023.1073538.


Step Count, Self-reported Physical Activity, and Predicted 5-Year Risk of Atrial Fibrillation: Cross-sectional Analysis.

Shapira-Daniels A, Kornej J, Spartano N, Wang X, Zhang Y, Pathiravasan C J Med Internet Res. 2023; 25:e43123.

PMID: 36877540 PMC: 10028513. DOI: 10.2196/43123.


Short-term prediction of atrial fibrillation from ambulatory monitoring ECG using a deep neural network.

Singh J, Fontanarava J, de Masse G, Carbonati T, Li J, Henry C Eur Heart J Digit Health. 2023; 3(2):208-217.

PMID: 36713004 PMC: 9708000. DOI: 10.1093/ehjdh/ztac014.


CHARGE-AF: A Useful Score For Atrial Fibrillation Prediction?.

Goudis C, Daios S, Dimitriadis F, Liu T Curr Cardiol Rev. 2022; 19(2):e010922208402.

PMID: 36056866 PMC: 10201902. DOI: 10.2174/1573403X18666220901102557.


References
1.
Renda G, Ricci F, Patti G, Aung N, Petersen S, Gallina S . CHADSVASc score and adverse outcomes in middle-aged individuals without atrial fibrillation. Eur J Prev Cardiol. 2019; 26(18):1987-1997. DOI: 10.1177/2047487319868320. View

2.
Hald J, Bo Poulsen P, Qvist I, Holm L, Wedell-Wedellsborg D, Dybro L . Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark-The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study. PLoS One. 2017; 12(11):e0188086. PMC: 5683635. DOI: 10.1371/journal.pone.0188086. View

3.
Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M . Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study. Circulation. 2015; 131(25):2176-84. DOI: 10.1161/CIRCULATIONAHA.114.014343. View

4.
Ding L, Li J, Wang C, Li X, Su Q, Zhang G . Incidence of atrial fibrillation and its risk prediction model based on a prospective urban Han Chinese cohort. J Hum Hypertens. 2017; 31(9):574-579. DOI: 10.1038/jhh.2017.23. View

5.
Hart R, Pearce L, Aguilar M . Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007; 146(12):857-67. DOI: 10.7326/0003-4819-146-12-200706190-00007. View